Riluzole
In the US, Riluzole (riluzole systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Amyotrophic Lateral Sclerosis and Obsessive Compulsive Disorder.
US matches:
UK matches:
- Riluzole Zentiva
- RILUZOLE 50MG FILM-COATED TABLETS (Leaflet)
- RILUZOLE ACTAVIS 50 MG FILM-COATED TABLETS (Leaflet)
- RILUZOLE MYLAN 50 MG FILM-COATED TABLETS (Leaflet)
- RILUZOLE MYLAN GENERICS 50 MG FILM-COATED TABLETS (Leaflet)
- RILUZOLE SUN 50 MG FILM-COATED TABLETS (Leaflet)
- RILUZOLE TEVA 50 MG FILM-COATED TABLETS (Leaflet)
- RILUZOLE ZENTIVA 50 MG FILM-COATED TABLETS (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N07XX02
CAS registry number (Chemical Abstracts Service)
0001744-22-5
Chemical Formula
C8-H5-F3-N2-O-S
Molecular Weight
234
Therapeutic Categories
Glutamate antagonist
Neuroprotective agent
Chemical Name
2-Benzothiazolamine, 6-(trifluoromethoxy)-
Foreign Names
- Riluzolum (Latin)
- Riluzol (German)
- Riluzole (French)
- Riluzol (Spanish)
Generic Names
- Riluzole (OS: BAN, DCF, USAN)
- PK 26124 (IS)
- RP 54274 (IS: RhônePoulencR)
- Riluzole (PH: USP 34)
Brand Names
- Fanizan
Actavis, Estonia - Laidec
Sun Pro, Taiwan - Lizolorol
Actavis, Estonia - Lizorolol
ratiopharm, Netherlands - Rilustad
STADA, Estonia - Rilutek
Aventis, Poland; Aventis, Slovenia; Aventis Pharma, Latvia; Aventis Pharma, Norway; Sanofi Aventis, Brazil; Sanofi Aventis, China; Sanofi Aventis, Spain; Sanofi Aventis, Japan; Sanofi Winthrop, Serbia; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Hungary; Sanofi-Aventis, Ireland; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, South Korea; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Mexico; Sanofi-Aventis, Netherlands; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Peru; Sanofi-Aventis, Portugal; Sanofi-Aventis, Romania; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan - Riluzol 1A Pharma
1A Pharma, Netherlands - Riluzol Actavis
Actavis, Netherlands - Riluzol CF
Centrafarm, Netherlands - Riluzol Generis
Generis, Portugal - Riluzol Hexal
Hexal, Netherlands - Riluzol Mylan
Mylan, Netherlands - Riluzol PMCS
PRO.MED.CS, Netherlands - Riluzol Sandoz
Sandoz, Netherlands - Riluzol Sun
Sun Pharma, Netherlands - Riluzol Teva
Teva, Netherlands - Riluzole Actavis
Actavis, Estonia; Actavis, Lithuania; Actavis, Latvia - Riluzole ESP Pharma
ESP Pharma, Estonia - Riluzole STADA
STADA, Estonia - Riluzole Teva
Teva, Estonia - Riluzole
Impax, United States - Riluzole-Nhwa Pharm
Nhwa, China - Rimipole
Actavis, Estonia - Sclefic
Actavis, Bulgaria; Actavis, Czech Republic; Actavis, Estonia; Actavis, Malta; Actavis, Slovenia - Xie Yi Li
Lunan Pharm, China - Zolerilis
Actavis, Estonia
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.


